Search

Deborah Crouch

Examiner (ID: 19500, Phone: (571)272-0727 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
3725, 1819, 1632, 2899, 1804
Total Applications
1439
Issued Applications
694
Pending Applications
237
Abandoned Applications
511

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5485737 [patent_doc_number] => 20090275502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCING DEVELOPMENTAL POTENTIAL OF OOCYTES AND PREIMPLANTATION EMBRYOS' [patent_app_type] => utility [patent_app_number] => 11/917675 [patent_app_country] => US [patent_app_date] => 2006-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25117 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275502.pdf [firstpage_image] =>[orig_patent_app_number] => 11917675 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/917675
METHODS AND COMPOSITIONS FOR ENHANCING DEVELOPMENTAL POTENTIAL OF OOCYTES AND PREIMPLANTATION EMBRYOS Jun 15, 2006 Abandoned
Array ( [id] => 5627263 [patent_doc_number] => 20060265768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Breeding and milking cows for milk free of beta-casein A1' [patent_app_type] => utility [patent_app_number] => 11/439114 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15525 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20060265768.pdf [firstpage_image] =>[orig_patent_app_number] => 11439114 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/439114
Breeding and milking cows for milk free of β-casein A1 May 23, 2006 Issued
Array ( [id] => 8796919 [patent_doc_number] => 08435787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Alginate polyelectrolyte encapsulation of embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 11/919407 [patent_app_country] => US [patent_app_date] => 2006-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10052 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11919407 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/919407
Alginate polyelectrolyte encapsulation of embryonic stem cells May 8, 2006 Issued
Array ( [id] => 5243988 [patent_doc_number] => 20070022483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Transgenic animal model for Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 11/413873 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2710 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20070022483.pdf [firstpage_image] =>[orig_patent_app_number] => 11413873 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/413873
Tau hyperphosphorylation in transgenic mice expressing the APP double mutation Apr 27, 2006 Issued
Array ( [id] => 5409532 [patent_doc_number] => 20090123430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'METHOD FOR DIFFERENTIATION OF STEM CELLS' [patent_app_type] => utility [patent_app_number] => 11/817652 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9302 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123430.pdf [firstpage_image] =>[orig_patent_app_number] => 11817652 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817652
Culture of mammalian pluripotent stem cells in the presence of hyaluronan induces differentiation into multi-lineage progenitor cells Mar 2, 2006 Issued
Array ( [id] => 5649047 [patent_doc_number] => 20060134782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Differentiated cells suitable for human therapy' [patent_app_type] => utility [patent_app_number] => 11/359341 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26845 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134782.pdf [firstpage_image] =>[orig_patent_app_number] => 11359341 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/359341
In vitro differentiated cell and human embryonic stem cell population Feb 20, 2006 Issued
Array ( [id] => 5619439 [patent_doc_number] => 20060188972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Targeted modification of chromatin structure' [patent_app_type] => utility [patent_app_number] => 11/357615 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30063 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188972.pdf [firstpage_image] =>[orig_patent_app_number] => 11357615 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/357615
Targeted modification of chromatin structure Feb 15, 2006 Abandoned
Array ( [id] => 5661466 [patent_doc_number] => 20060252062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'System and process for genetic and epigenetic treatment' [patent_app_type] => utility [patent_app_number] => 11/352299 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8704 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252062.pdf [firstpage_image] =>[orig_patent_app_number] => 11352299 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/352299
System and process for genetic and epigenetic treatment Feb 12, 2006 Abandoned
Array ( [id] => 4476715 [patent_doc_number] => 07906330 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Two cell population comprising chondrocyte precursors and human embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 11/345878 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8007 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906330.pdf [firstpage_image] =>[orig_patent_app_number] => 11345878 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/345878
Two cell population comprising chondrocyte precursors and human embryonic stem cells Jan 31, 2006 Issued
Array ( [id] => 5342341 [patent_doc_number] => 20090180991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'METHOD FOR TREATING INFLAMMATION ASSOCIATED WITH AMYLOID DEPOSITS AND BRAIN INFLAMMATION INVOLVING ACTIVATED MICROGLIA' [patent_app_type] => utility [patent_app_number] => 11/815294 [patent_app_country] => US [patent_app_date] => 2006-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10846 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20090180991.pdf [firstpage_image] =>[orig_patent_app_number] => 11815294 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/815294
Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia Jan 30, 2006 Issued
Array ( [id] => 5778700 [patent_doc_number] => 20060107340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto' [patent_app_type] => utility [patent_app_number] => 11/329010 [patent_app_country] => US [patent_app_date] => 2006-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23348 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20060107340.pdf [firstpage_image] =>[orig_patent_app_number] => 11329010 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/329010
Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto Jan 7, 2006 Abandoned
Array ( [id] => 52810 [patent_doc_number] => 07772001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Directed differentiation of embryonic stem cells into an endoderm cell' [patent_app_type] => utility [patent_app_number] => 11/322523 [patent_app_country] => US [patent_app_date] => 2006-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 8511 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772001.pdf [firstpage_image] =>[orig_patent_app_number] => 11322523 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/322523
Directed differentiation of embryonic stem cells into an endoderm cell Jan 2, 2006 Issued
Array ( [id] => 4886390 [patent_doc_number] => 20080260722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Method for High Efficiency Survival/Proliferation of Human Embyonic Stem Cells and Human Embryo Survival in Culture' [patent_app_type] => utility [patent_app_number] => 11/794455 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 15704 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260722.pdf [firstpage_image] =>[orig_patent_app_number] => 11794455 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/794455
Method for High Efficiency Survival/Proliferation of Human Embyonic Stem Cells and Human Embryo Survival in Culture Dec 29, 2005 Abandoned
Array ( [id] => 5666581 [patent_doc_number] => 20060171931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Methods and compositions for modulating stem cell growth and differentiation' [patent_app_type] => utility [patent_app_number] => 11/318419 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28112 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171931.pdf [firstpage_image] =>[orig_patent_app_number] => 11318419 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/318419
Growth and differentiation of adult muscle stem cells with activators or inhibitors of Wnt signaling Dec 21, 2005 Issued
Array ( [id] => 5865054 [patent_doc_number] => 20060099184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors' [patent_app_type] => utility [patent_app_number] => 11/303896 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15923 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099184.pdf [firstpage_image] =>[orig_patent_app_number] => 11303896 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/303896
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors Dec 14, 2005 Abandoned
Array ( [id] => 5865055 [patent_doc_number] => 20060099185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Methods of treating anemia using recombinant adeno-associated virus virions' [patent_app_type] => utility [patent_app_number] => 11/305629 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16501 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099185.pdf [firstpage_image] =>[orig_patent_app_number] => 11305629 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/305629
Methods of treating anemia using recombinant adeno-associated virus virions Dec 14, 2005 Abandoned
Array ( [id] => 5742787 [patent_doc_number] => 20060088512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Treatment of T cell disorders' [patent_app_type] => utility [patent_app_number] => 11/296676 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 15342 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088512.pdf [firstpage_image] =>[orig_patent_app_number] => 11296676 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/296676
Treatment of T cell disorders Dec 6, 2005 Abandoned
Array ( [id] => 352844 [patent_doc_number] => 07491867 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-17 [patent_title] => 'Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates' [patent_app_type] => utility [patent_app_number] => 11/291668 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 44 [patent_no_of_words] => 31439 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491867.pdf [firstpage_image] =>[orig_patent_app_number] => 11291668 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/291668
Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates Nov 30, 2005 Issued
Array ( [id] => 5615465 [patent_doc_number] => 20060117395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates' [patent_app_type] => utility [patent_app_number] => 11/292164 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 31478 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20060117395.pdf [firstpage_image] =>[orig_patent_app_number] => 11292164 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/292164
Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates Nov 30, 2005 Abandoned
Array ( [id] => 5847780 [patent_doc_number] => 20060123503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 11/285580 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32814 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20060123503.pdf [firstpage_image] =>[orig_patent_app_number] => 11285580 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/285580
V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto Nov 20, 2005 Abandoned
Menu